Cargando…
Fludarabine-Based Low-Intensity Conditioning for Fanconi Anemia is Associated with Good Outcomes in Aplastic Anemia but not in MDS - a Single-Center Experience
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with Fanconi Anemia (FA) with hematological abnormalities. MATERIALS AND METHODS: This is a retrospective analysis of patients with FA who underwent a matched-related donor HSCT. RESULTS: Sixty patien...
Autores principales: | Chattopadhyay, Sohini, Lionel, Sharon, Selvarajan, Sushil, Devasia, Anup J, Korula, Anu, Kulkarni, Uday, NA, Fouzia, Sindhuvi, Eunice, Lakshmi, Kavitha M, Srivastava, Alok, Abraham, Aby, Mathews, Vikram, George, Biju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332348/ https://www.ncbi.nlm.nih.gov/pubmed/37435039 http://dx.doi.org/10.4084/MJHID.2023.039 |
Ejemplares similares
-
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017) -
Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018) -
Hematopoietic Stem Cell Transplantation is a cost-effective alternative to enzyme replacement therapy in Gaucher Disease
por: Aboobacker, Fouzia N, et al.
Publicado: (2022) -
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017) -
Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin
por: Yang, Dan, et al.
Publicado: (2019)